Døssing, K.B.V.; Kjær, C.; Vikeså, J.; Binderup, T.; Knigge, U.; Culler, M.D.; Kjær, A.; Federspiel, B.; Friis-Hansen, L.
Somatostatin Analogue Treatment Primarily Induce miRNA Expression Changes and Up-Regulates Growth Inhibitory miR-7 and miR-148a in Neuroendocrine Cells. Genes 2018, 9, 337.
https://doi.org/10.3390/genes9070337
AMA Style
Døssing KBV, Kjær C, Vikeså J, Binderup T, Knigge U, Culler MD, Kjær A, Federspiel B, Friis-Hansen L.
Somatostatin Analogue Treatment Primarily Induce miRNA Expression Changes and Up-Regulates Growth Inhibitory miR-7 and miR-148a in Neuroendocrine Cells. Genes. 2018; 9(7):337.
https://doi.org/10.3390/genes9070337
Chicago/Turabian Style
Døssing, Kristina B. V., Christina Kjær, Jonas Vikeså, Tina Binderup, Ulrich Knigge, Michael D. Culler, Andreas Kjær, Birgitte Federspiel, and Lennart Friis-Hansen.
2018. "Somatostatin Analogue Treatment Primarily Induce miRNA Expression Changes and Up-Regulates Growth Inhibitory miR-7 and miR-148a in Neuroendocrine Cells" Genes 9, no. 7: 337.
https://doi.org/10.3390/genes9070337
APA Style
Døssing, K. B. V., Kjær, C., Vikeså, J., Binderup, T., Knigge, U., Culler, M. D., Kjær, A., Federspiel, B., & Friis-Hansen, L.
(2018). Somatostatin Analogue Treatment Primarily Induce miRNA Expression Changes and Up-Regulates Growth Inhibitory miR-7 and miR-148a in Neuroendocrine Cells. Genes, 9(7), 337.
https://doi.org/10.3390/genes9070337